CliniGA CRO

CliniGA CRO Blog

RTSM Test Environments: Preventing Practice from Creating Real Assignments

Test RTSM environment separation in realistic workflows to prevent training or test actions from creating real assignments.

Representative research photograph: RTSM Test Environments: Preventing Practice from Creating Real Assignments
Photo: Department of Foreign Affairs and Trade · License: CC BY 2.0 · Cropped and resized.
Published
Updated

A training or testing action in a randomisation and trial-supply system can affect a real study when the wrong environment is selected. An environment label on screen does not prove that every integration points to the intended destination.

Preserve the meaning of data

Separate test and production access, connection targets, notifications and exports. Define the expected behaviour that a test participant cannot generate a real supply order or site instruction. Verifying the scientific randomisation design is different from preventing actions in the wrong environment. Protect information requiring blinding in test screens and evidence as well.

Worked example

For example, a training session creates a demonstration participant while an integration remains connected to the live logistics service. The team tests the complete flow using safe test identities and non-production delivery targets. It assesses any records and notifications the incorrect link could have created rather than closing the issue after changing the training screen alone.

Review checks

  • Compare environment indicators with actual integration destinations.
  • Confirm that test notifications and supply requests cannot reach production.
  • Check that blinded information is not unnecessarily exposed in test evidence.

Acceptance and boundaries

Acceptance means defined test actions do not create production records, real supply requests or participant decisions. This control does not change randomisation authority or provide emergency clinical instructions. Reassess connections when environments are copied or integrations replaced. Keep the trusted configuration version and responsible change owner understandable for subsequent review.

Frequently asked questions

Is a different screen colour enough?
It helps users, but connection targets and actual transaction effects need separate verification.
Can production data be used for training?
Do not copy it without assessing need and access; suitable synthetic examples may be preferable.

Sources

  1. FDA — Electronic systems, records and signatures in clinical investigations
  2. MHRA — Guidance on GxP data integrity